AG
PRTK

Advisor Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Advisor Group’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$26K Buy
6,425
+3,512
+121% +$12.2K ﹤0.01% 3831
2019
Q3 		$13K Buy
2,913
+913
+46% +$3.65K ﹤0.01% 4216
2019
Q2 		$8K Hold
2,000
– – ﹤0.01% 4496
2019
Q1 		$11K Buy
+2,000
New +$12.9K ﹤0.01% 4338

Other funds holding PRTK

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Advisor Group's PRTK Position: Q4 2019 in Review

Advisor Group increased its Paratek Pharmaceuticals, Inc. (PRTK) stake by 121% in Q4 2019, buying an estimated $12.2K and bringing the position to 6,425 shares worth $26K. The position accounts for ﹤0.01% of the portfolio, ranked #3831.

Advisor Group first reported a position in PRTK in Q1 2019 and has held it in 4 quarters since. 93 funds tracked by Wall St. Rank hold PRTK as of Q4 2019.

  • Advisor Group held 6,425 shares of Paratek Pharmaceuticals, Inc. worth $26K as of Q4 2019.
  • Advisor Group bought 3,512 Paratek Pharmaceuticals, Inc. shares in Q4 2019, an estimated $12.2K.
  • Paratek Pharmaceuticals, Inc. made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3831 holding.
  • Advisor Group first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2019 and has held it in 4 quarters since.
  • 93 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.